Microscale culture of human liver cells for drug development
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tissue function depends on hierarchical structures extending from single cells ( approximately 10 microm) to functional subunits (100 microm-1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved and have the advantages of miniaturization. Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity. We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, hepatic models that utilize conventional 2D mono-and co-cultures of normal and diseased human cells fail to mimic the complex threedimensional (3D) in vivo microenvironment and extracellular matrix (ECM) support [16,19,20].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [16]
In the citing paper
“The oxygenated or microfabricated co-cultures have been reported to allow HHs to retain metabolic function for a few weeks; however, these cells lose their proliferative capacity (Khetani and Bhatia, 2008; Kidambi et al., 2009”
From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Khetani and Bhatia, 2008
Citations
Cites
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657 · cited 1×
“Over the last decade, microtechnology tools have emerged to probe biomedical phenomena at relevant length scales and to miniaturize and parallelize biomedical assay”
BackgroundRheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Soft Lithography in Biology and Biochemistry
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X., & Ingber, D. E. (2001) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.3.1.335 · Cited by 2,607 · cited 1×
“Our approach incorporates 'soft lithography' techniques, using reusable, elastomeric molds of microfabricated structures to overcome limitations of photolithograph”
MethodIdiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054 · cited 1×
“The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicit”
BackgroundGenome-wide expression monitoring in Saccharomyces cerevisiae
Wodicka, L., Dong, H., Mittmann, M., Ho, M.-H., & Lockhart, D. J. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1359 · Cited by 973
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Self-citationWilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 1×
“Although hepatocarcinoma-derived cell lines and immortalized hepatocytes can be reproducible and inexpensive, they display abnormal levels of liver-specific function”
BackgroundHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Cited by
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Self-citationUygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
“Primary hepatocytes are known to require between 7 and 10 d in culture before their metabolic activity and gene transcription levels stabiliz”
BackgroundHighly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas
von Maltzahn, G., Park, J.-H., Agrawal, A., Bandaru, N. K., Das, S. K., Sailor, M. J., & Bhatia, S. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4242 · Cited by 1,051
“After 24 hours of incubation above primary rat hepatocyte cocultures, an in vitro liver model that was previously used to elucidate semiconductor quantum dot toxicity (26) and has shown utility for rank-ordering pharmacologic toxicities (27), PEG-NRs, displayed no significant alterations in mitochondrial activity comp…”
BackgroundSelf-citationAdvances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting
Ma, X., Qu, X., Zhu, W., Li, Y.-S., Yuan, S., Zhang, H., Liu, J., Wang, P., Lai, C. S. E., Zanella, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524510113 · Cited by 872
“The greater HPC aggregate size observed in this 3D triculture model further supports the beneficial effects from supporting cells as widely reported in 2D coculture models (14, 42).”
BackgroundResultInspiration and application in the evolution of biomaterials
Huebsch, N., & Mooney, D. J. (2009) · Nature · doi:10.1038/nature08601 · Cited by 855
“These biomaterials are designed on multiple length scales to present and organize arrays of molecules and cells for mechanistic studies and drug screenin”
BackgroundLong-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
Hu, H., Gehart, H., Artegiani, B., LÖpez-Iglesias, C., Dekkers, F., Basak, O., van Es, J., Chuva de Sousa Lopes, S. M., Begthel, H., Korving, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.013 · Cited by 837
“Co-culture systems or expression of HPV genes have been described to support limited hepatocyte expansion (Khetani and Bhatia, 2008; Levy et al., 2015).”
Zhang, Y. S., Aleman, J., Shin, S. R., Kilic, T., Kim, D., Mousavi Shaegh, S. A., Massa, S., Riahi, R., Chae, S., Hu, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612906114 · Cited by 833
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Organogenesis and development of the liver
Si-Tayeb, K., Lemaigre, F. P., & Duncan, S. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.01.011 · Cited by 800
Micropatterning as a tool to decipher cell morphogenesis and functions
Théry, M. (2010) · Journal of Cell Science · doi:10.1242/jcs.075150 · Cited by 730
“The coculture of two micropatterned cell types allowed to identify the parameters in homo- and heterotypic interactions that determine the acquisition of defined multicellular functions, such as liver morphogenesis (Bhatia et al., 1998; Khetani and Bhatia, 2008).”
BackgroundAcoustic tweezers: patterning cells and microparticles using standing surface acoustic waves (SSAW)
Shi, J., Ahmed, D., Mao, X., Lin, S.-C. S., Lawit, A., & Huang, T. J. (2009) · Lab on a Chip · doi:10.1039/b910595f · Cited by 723
Microfabrication of human organs-on-chips
Huh, D., Kim, H. J., Fraser, J. P., Shea, D. E., Khan, M., Bahinski, A., Hamilton, G. A., & Ingber, D. E. (2013) · Nature Protocols · doi:10.1038/nprot.2013.137 · Cited by 712
3D Bioprinting for Tissue and Organ Fabrication
Zhang, Y. S., Yue, K., Aleman, J., Mollazadeh-Moghaddam, K., Bakht, S. M., Yang, J., Jia, W., Dell’Erba, V., Assawes, P., Shin, S. R., et al. (2017) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1612-8 · Cited by 682
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
“Liver OOCs contain hepatocytes and fibroblasts arranged in meaningful ways by patterning (Khetani and Bhatia, 2008; Cho et al., 2010) or cultured in aggregates (Ramaiahgari et al., 2014; Bhise et al., 2016).”
BackgroundA liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Generation and Regeneration of Cells of the Liver and Pancreas
Zaret, K. S., & Grompe, M. (2008) · Science · doi:10.1126/science.1161431 · Cited by 588
Engineered In Vitro Disease Models
Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., et al. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040418 · Cited by 554
“To meet this challenge, a multiwell system was fabricated in which microislands of hepatocytes are surrounded by supportive stromal cells (3T3 rat fibroblasts) (190).”
MethodContinuous particle separation in a microfluidic channel via standing surface acoustic waves (SSAW)
Shi, J., Huang, H., Stratton, Z., Huang, Y., & Huang, T. J. (2009) · Lab on a Chip · doi:10.1039/b915113c · Cited by 547
New developments in anti-malarial target candidate and product profiles
Burrows, J. N., Duparc, S., Gutteridge, W. E., Hooft van Huijsduijnen, R., Kaszubska, W., Macintyre, F., Mazzuri, S., Möhrle, J. J., & Wells, T. N. C. (2017) · Malaria Journal · doi:10.1186/s12936-016-1675-x · Cited by 520
Differentiation and Transplantation of Human Embryonic Stem Cell–Derived Hepatocytes
Basma, H., Soto–Gutiérrez, A., Yannam, G. R., Liu, L., Ito, R., Yamamoto, T., Ellis, E., Carson, S. D., Sato, S., Chen, Y., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.047 · Cited by 516
Predicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502
“These systems provide a much more “organ-like environment” for cells, which can be maintained for long periods whilst being exposed to drugs in order to assess metabolism and toxicity 100-102 .”
BackgroundIn vitro models for liver toxicity testing
Soldatow, V. Y., LeCluyse, E. L., Griffith, L. G., & Rusyn, I. (2013) · Toxicol. Res. · doi:10.1039/c2tx20051a · Cited by 472
Additive Manufacturing of Biomaterials, Tissues, and Organs
Zadpoor, A. A., & Malda, J. (2017) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1719-y · Cited by 462
Adaptation of High-Throughput Screening in Drug Discovery—Toxicological Screening Tests
Szymański, P., Markowicz, M., & Mikiciuk-Olasik, E. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms13010427 · Cited by 454
Organ-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Van Voorhis, W. C., Adams, J. H., Adelfio, R., Ahyong, V., Akabas, M. H., Alano, P., Alday, A., Alemán Resto, Y., Alsibaee, A., Alzualde, A., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005763 · Cited by 435
“To flag such interactions, we employed two recent breakthrough models: a bioengineered microscale human liver in a high-throughput assay format that accurately captures human drug-drug interactions not detectable in animals or cell lines [7] and a custom-made, robotic highthroughput Luminex bead-based method for profi…”
Self-citationMicrofluidic cell culture systems for drug research
Wu, M.-H., Huang, S.-B., & Lee, G.-B. (2010) · Lab on a Chip · doi:10.1039/b921695b · Cited by 432
Astashkina, A., Mann, B., & Grainger, D. W. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.001 · Cited by 424
A microfluidic 3D hepatocyte chip for drug toxicity testing
Toh, Y.-C., Lim, T. C., Tai, D., Xiao, G., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b900912d · Cited by 419
Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
Saha, K., & Jaenisch, R. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.11.009 · Cited by 411
Nanotechnology, nanotoxicology, and neuroscience
Suh, W. H., Suslick, K. S., Stucky, G. D., & Suh, Y.-H. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.009 · Cited by 406
Ma, X., Liu, J., Zhu, W., Tang, M., Lawrence, N., Yu, C., Gou, M., & Chen, S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.011 · Cited by 401
Microfluidic Devices for Drug Delivery Systems and Drug Screening
Damiati, S., Kompella, U. B., Damiati, S. A., & Kodzius, R. (2018) · Genes · doi:10.3390/genes9020103 · Cited by 383
“and transport of liver products, and susceptibility to hepatotoxins [164].”
BackgroundOrgan-on-a-chip platforms for studying drug delivery systems
Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381
“Assessment of nanoparticles should be evaluatedwithin such clinically relevant models that can maintain the functionality of primary hepatocytes for long-term culture [86,94].”
BackgroundMethodOrganotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Biomimetic tissues on a chip for drug discovery
Ghaemmaghami, A. M., Hancock, M. J., Harrington, H., Kaji, H., & Khademhosseini, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.029 · Cited by 359
“, pp. 115–138, Humana Press 72 Khetani, S.R. and Bhatia, S.N. (2008) Microscale culture of human liver cells for drug development.”
BackgroundMethodInfluentialHepatitis E virus: advances and challenges
Nimgaonkar, I., Ding, Q., Schwartz, R. E., & Ploss, A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.150 · Cited by 352
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“…demonstrated increased CYP450 activity and improved stability of liver phenotype over time in culture compared to monocultures of primary hepatocytes (Khetani and Bhatia 2008), which was hypothesized to be driving in part the increased sensitivity towards hepatotoxicants (Khetani et al. 2013).”
BackgroundInfluentialOrgan-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Organs-on-chips: breaking the in vitro impasse
Meer, A. D. V. D., & Berg, A. V. D. (2012) · Integrative Biology · doi:10.1039/c2ib00176d · Cited by 314
Cell and tissue engineering for liver disease
Bhatia, S. N., Underhill, G. H., Zaret, K. S., & Fox, I. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005975 · Cited by 309
“For instance, micropatterned co-cultures of hepatocytes and fibroblasts, fabricated with either photolithography or soft lithography techniques, have been used to precisely regulate homotypic and heterotypic interactions and have been optimized to support hepatocyte phenotypic functions for several weeks, including th…”
MethodSelf-citationTowards artificial tissue models: past, present, and future of 3D bioprinting
Arslan-Yildiz, A., Assal, R. E., Chen, P., Guven, S., Inci, F., & Demirci, U. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014103 · Cited by 301
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies†
Popov, Y., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23123 · Cited by 296
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
“…described above, MPS-based single-organ liver modeling has led to a large variety of liver-on-achip devices (Baudoin et al., 2014a; Hwa et al., 2007; Kane et al., 2006; Khetani and Bhatia, 2008; Leclerc et al., 2014, 2015; Legendre et al., 2013, 2014; Pasirayi et al., 2014; Snouber et al., 2013).”
Gröger, M., Rennert, K., Giszas, B., Weiß, E., Dinger, J., Funke, H., Kiehntopf, M., Peters, F. T., Lupp, A., Bauer, M., et al. (2018) · Scientific Reports · doi:10.1038/srep46988 · Cited by 293
3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing
Takayama, K., Kawabata, K., Nagamoto, Y., Kishimoto, K., Tashiro, K., Sakurai, F., Tachibana, M., Kanda, K., Hayakawa, T., Furue, M. K., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.029 · Cited by 289
Fernandes, T. G., Diogo, M. M., Clark, D. S., Dordick, J. S., & Cabral, J. M. S. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.02.009 · Cited by 285
Fabrication of three-dimensional porous cell-laden hydrogel for tissue engineering
Hwang, C. M., Sant, S., Masaeli, M., Kachouie, N. N., Zamanian, B., Lee, S.-H., & Khademhosseini, A. (2010) · Biofabrication · doi:10.1088/1758-5082/2/3/035003 · Cited by 285
Pluripotent stem cell-derived hepatocyte-like cells
Schwartz, R. E., Fleming, H. E., Khetani, S. R., & Bhatia, S. N. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.01.003 · Cited by 282
“Β-Naphthloflavone (CYP1A2, CYP2B6) [52] NT +”
InfluentialSelf-citationEvolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip
Azizipour, N., Avazpour, R., Rosenzweig, D. H., Sawan, M., & Ajji, A. (2020) · Micromachines · doi:10.3390/mi11060599 · Cited by 277
Recent Advances in Body-on-a-Chip Systems
Sung, J. H., Wang, Y. I., Narasimhan Sriram, N., Jackson, M., Long, C., Hickman, J. J., & Shuler, M. L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05293 · Cited by 268
Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis
Iorga, A., Dara, L., & Kaplowitz, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051018 · Cited by 268
“Like the other models, iPSCs have limitations as well, mainly due to poor differentiation of cells to hepatocytes [175].”
BackgroundKostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262
“For example, human hepatocytes in a 2D micro-patterned co-culture with mouse 3 T3-J2 fibroblasts (Khetani and Bhatia, 2008) maintained hepatocellular function for several weeks.”
BackgroundShlomai, A., Schwartz, R. E., Ramanan, V., Bhatta, A., de Jong, Y. P., Bhatia, S. N., & Rice, C. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412631111 · Cited by 258
“We have previously developed a miniaturized system in which primary hepatocytes are organized in micropatterned colonies and surrounded by supportive stromal cells, providing hepatocytes with the necessary homotypic and heterotypic cell–cell interactions to promote long-term maintenance of their hepatic function (12).”
InfluentialSelf-citationDiversity-oriented synthesis yields novel multistage antimalarial inhibitors
Kato, N., Comer, E., Sakata-Kato, T., Sharma, A., Sharma, M., Maetani, M., Bastien, J., Brancucci, N. M., Bittker, J. A., Corey, V., et al. (2016) · Nature · doi:10.1038/nature19804 · Cited by 255
“Hepatocytes in this format maintain a functional phenotype for up to 4–6 weeks without proliferation, as assessed by major liver-specific functions and gene expression 47–49 .”
Self-citationIdentification of small molecules for human hepatocyte expansion and iPS differentiation
Shan, J., Schwartz, R. E., Ross, N. T., Logan, D. J., Thomas, D., Duncan, S. A., North, T. E., Goessling, W., Carpenter, A. E., & Bhatia, S. N. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1270 · Cited by 254
Self-citationIn Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity
Zhang, K., Zhang, L., Liu, W., Ma, X., Cen, J., Sun, Z., Wang, C., Feng, S., Zhang, Z., Yue, L., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.018 · Cited by 252
“The oxygenated or microfabricated co-cultures have been reported to allow HHs to retain metabolic function for a few weeks; however, these cells lose their proliferative capacity (Khetani and Bhatia, 2008; Kidambi et al., 2009).”
BackgroundReal-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
Jones, C. T., Catanese, M. T., Law, L. M. J., Khetani, S. R., Syder, A. J., Ploss, A., Oh, T. S., Schoggins, J. W., MacDonald, M. R., Bhatia, S. N., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1604 · Cited by 249
“We reasoned that the sensitivity of HDFR might circumvent these difficulties, and explored its use for detecting HCV infection in the recently developed micropattern co-culture (MPCC) syste”
BackgroundSelf-citationYamada, M., Utoh, R., Ohashi, K., Tatsumi, K., Yamato, M., Okano, T., & Seki, M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.068 · Cited by 247
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012) · Hepatology · doi:10.1002/hep.24760 · Cited by 246
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Temperature-responsive intelligent interfaces for biomolecular separation and cell sheet engineering
Nagase, K., Kobayashi, J., & Okano, T. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0499.focus · Cited by 241
Microfluidics‐based 3D cell culture models: Utility in novel drug discovery and delivery research
Gupta, N., Liu, J. R., Patel, B., Solomon, D. E., Vaidya, B., & Gupta, V. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10013 · Cited by 236
“Khetani and Bhatia developed a multiwall micropatterned coculture system comprising of hepatocytes along with endothelial cells, stellar cells, Kupffer cells, and fibroblasts.(94) This chip was able to maintain phenotypic functions for several weeks.”
BackgroundTavana, H., Jovic, A., Mosadegh, B., Lee, Q. Y., Liu, X., Luker, K. E., Luker, G. D., Weiss, S. J., & Takayama, S. (2009) · Nature Materials · doi:10.1038/nmat2515 · Cited by 235
“dtd" [ ]> Microscale biopatterning enables regulation of cell–material interaction”
Sung, J. H., Esch, M. B., Prot, J.-M., Long, C. J., Smith, A., Hickman, J. J., & Shuler, M. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41017j · Cited by 233
Liver-cell patterning lab chip: mimicking the morphology of liver lobule tissue
Ho, C.-T., Lin, R.-Z., Chen, R.-J., Chin, C.-K., Gong, S.-E., Chang, H.-Y., Peng, H.-L., Hsu, L., Yew, T.-R., Chang, S.-F., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50402f · Cited by 230
Emerging Roles for Extracellular Vesicles in Tissue Engineering and Regenerative Medicine
Lamichhane, T. N., Sokic, S., Schardt, J. S., Raiker, R. S., Lin, J. W., & Jay, S. M. (2015) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0300 · Cited by 230
“Beyond what has been discussed above, the development of engineered tissues as both model systems for drug development 86,87 or for study of complex biology in vitro would benefit from consideration of the roles of EVs.”
Deng, J., Wei, W., Chen, Z., Lin, B., Zhao, W., Luo, Y., & Zhang, X. (2019) · Micromachines · doi:10.3390/mi10100676 · Cited by 229
Emergence of microfluidics for next generation biomedical devices
Preetam, S., Nahak, B. K., Patra, S., Toncu, D. C., Park, S., Syväjärvi, M., Orive, G., & Tiwari, A. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100106 · Cited by 225
Organs-on-a-chip: a new tool for drug discovery
Polini, A., Prodanov, L., Bhise, N. S., Manoharan, V., Dokmeci, M. R., & Khademhosseini, A. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.886562 · Cited by 223
“To address the challenge of maintaining the functionality of hepatocytes, many systems have employed co-culture techniques by growing hepatocytes with other liver cells, such as Kupffer cells, stellate cells, endothelial cells and fibroblasts, with the primary goal of improving their metabolic activity [34-38].”
BackgroundMethodSi-Tayeb, K., Noto, F. K., Sepac, A., Sedlic, F., Bosnjak, Z. J., Lough, J. W., & Duncan, S. A. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-81 · Cited by 220
“DCF, however, can be secreted between hepatocyte-like cells via bile canaliculi through specific transporters [16].”
BackgroundMicrofluidics for Manipulating Cells
Mu, X., Zheng, W., Sun, J., Zhang, W., & Jiang, X. (2013) · Small · doi:10.1002/smll.201200996 · Cited by 214
Kidambi, S., Yarmush, R. S., Novik, E., Chao, P., Yarmush, M. L., & Nahmias, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906820106 · Cited by 213
“Moreover, as function in oxygenated co-cultures does not require 7 to 10 days to stabilize (6, 14), this culture technique significantly reduces overall labor and cost.”
BackgroundMethodInfluentialModeling hepatitis C virus infection using human induced pluripotent stem cells
Schwartz, R. E., Trehan, K., Andrus, L., Sheahan, T. P., Ploss, A., Duncan, S. A., Rice, C. M., & Bhatia, S. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121400109 · Cited by 213
“Adult human hepatocytes (heps) (15) are included as a reference.”
BackgroundSelf-citationControlled assembly of heterotypic cells in a core–shell scaffold: organ in a droplet
Chen, Q., Utech, S., Chen, D., Prodanovic, R., Lin, J.-M., & Weitz, D. A. (2016) · Lab on a Chip · doi:10.1039/c6lc00231e · Cited by 213
3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration
Wang, H., Brown, P. C., Chow, E. C. Y., Ewart, L., Ferguson, S. S., Fitzpatrick, S., Freedman, B. S., Guo, G. L., Hedrich, W., Heyward, S., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.13066 · Cited by 212
March, S., Ng, S., Velmurugan, S., Galstian, A., Shan, J., Logan, D. J., Carpenter, A. E., Thomas, D., Sim, B. K. L., Mota, M. M., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.005 · Cited by 212
“Fibroblast medium was replaced with human hepatocyte medium 24 h after fibroblast seeding and subsequently replaced daily (Khetani and Bhatia, 2008).”
InfluentialSelf-citationPersistent hepatitis C virus infection in microscale primary human hepatocyte cultures
Ploss, A., Khetani, S. R., Jones, C. T., Syder, A. J., Trehan, K., Gaysinskaya, V. A., Mu, K., Ritola, K., Rice, C. M., & Bhatia, S. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915130107 · Cited by 211
“, collagen gel sandwich, Matrigel overlay, and randomly distributed cocultures) could not sustain HCV replication, presumably due to a decline in liver-specific phenotype (12) (Fig.”
BackgroundMethodInfluentialSelf-citationDesign, fabrication and characterization of drug delivery systems based on lab-on-a-chip technology
Nguyen, N.-T., Shaegh, S. A. M., Kashaninejad, N., & Phan, D.-T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.008 · Cited by 210
“In vitro (pharmaco-kinetics) 1) Brain-on-a-chip [58, 59] 2) Heart-on-a-chip [60] 3) Liver-on-a-chip [13, 61-64] 4) Lung-on-a-chip [3, 65, 66] 5) Kidney-on-a-chip [67, 68] 6) Spleen-on-a-chip [51] 7) Intestine-on-a-chip [51, 69] 8) Gut-on-a-chip [70, 71] 9) Cornea-on-a-chip [60] 10) Blood vessel-on-a-chip [72-79] 11) M…”
Use of Decellularized Porcine Liver for Engineering Humanized Liver Organ
Barakat, O., Abbasi, S., Rodriguez, G., Rios, J., Wood, R. P., Ozaki, C., Holley, L. S., & Gauthier, P. K. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2011.09.033 · Cited by 208
Beckwitt, C. H., Clark, A. M., Wheeler, S., Taylor, D. L., Stolz, D. B., Griffith, L., & Wells, A. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.023 · Cited by 208
Use of Micropatterned Cocultures to Detect Compounds That Cause Drug-Induced Liver Injury in Humans
Khetani, S. R., Kanchagar, C., Ukairo, O., Krzyzewski, S., Moore, A., Shi, J., Aoyama, S., Aleo, M., & Will, Y. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs326 · Cited by 208
Self-citationDigital microfabrication of user‐defined 3D microstructures in cell‐laden hydrogels
Soman, P., Chung, P. H., Zhang, A. P., & Chen, S. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24957 · Cited by 207
Design of three‐dimensional biomimetic scaffolds
Owen, S. C., & Shoichet, M. S. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32834 · Cited by 206
“have shown that hepatocytes co-cultured with fibroblasts restore the appropriate hepatocellular phenotype.(49) Further work has also shown the dependency of liver sinusoidal endothelial cells (LSECs) on neighboring cells.”
Yoon No, D., Lee, K.-H., Lee, J., & Lee, S.-H. (2015) · Lab on a Chip · doi:10.1039/c5lc00611b · Cited by 205
Microfluidic organ-on-a-chip models of human liver tissue
Moradi, E., Jalili-Firoozinezhad, S., & Solati-Hashjin, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.041 · Cited by 204
Competency of different cell models to predict human hepatotoxic drugs
Gómez-Lechón, M. J., Tolosa, L., Conde, I., & Donato, M. T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967680 · Cited by 199
“Co-cultures of several liver-derived cell types Improved longevity/functionality of all cell types Higher expression of CYP and Phase II isoforms than in monotypic culture Inducibility of CYP enzymes by xenobiotics Good correlation with in vivo data (human hepatocytes) Recovery of morphology, bile canaliculi, and cell…”
BackgroundOrgans-on-a-Chip: A Focus on Compartmentalized Microdevices
Moraes, C., Mehta, G., Lesher-Perez, S. C., & Takayama, S. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0455-6 · Cited by 199
Pu, H.-L., Chiang, W.-L., Maiti, B., Liao, Z.-X., Ho, Y.-C., Shim, M. S., Chuang, E.-Y., Xia, Y., & Sung, H.-W. (2014) · ACS Nano · doi:10.1021/nn4058787 · Cited by 196
Astashkina, A., & Grainger, D. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.008 · Cited by 195
Berger, D. R., Ware, B. R., Davidson, M. D., Allsup, S. R., & Khetani, S. R. (2015) · Hepatology · doi:10.1002/hep.27621 · Cited by 195
“Monolayer cultures were maintained in serum-free culture medium (500 μL/well) with daily replacement of medium as previously described.(1)”
InfluentialSelf-citationWare, B. R., Berger, D. R., & Khetani, S. R. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv048 · Cited by 195
“Thus, PHHs are considered ideal for drug metabolism and toxicology assessments because they retain phenotypic functions for several weeks in vitro when subjected to appropriate culture conditions (Godoy et al., 2013; Khetani and Bhatia, 2008).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Khetani, S. R., & Bhatia, S. N.
- Affiliations
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Bhatia, Sangeeta N
- Venue
- Nature Biotechnology
- Published
- 2007-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 120-126
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2023296392
- Cited by
- 1,219
- References
- 41
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 36 · 2023: 49 · 2022: 64 · 2021: 56 · 2020: 68 · 2019: 73 · 2018: 81 · 2017: 86 · 2016: 93 · 2015: 77 · 2014: 76 · 2013: 90 · 2012: 75
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- human liver cells, liver-on-a-chip, hepatotoxicity, drug development, phase I and II metabolism, canalicular transport, hepatocyte secretion, gene expression profiling, tissue engineering, microtechnology
- MeSH terms
- Biological Assay, Cells, Cultured, Equipment Design, Humans, Miniaturization, Drug Design, Flow Injection Analysis, Cell Culture Techniques, Equipment Failure Analysis, Hepatocytes, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.